Arbutus Biopharma Corp — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arbutus Biopharma Corp (ABUS)
CIK: 0001447028
Period of Report: 2021-02-13

Reporting Person: HASTINGS DAVID C (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-13	Stock Options	$4.33	A	250000	Acquired	2031-02-13	Common Stock (250000.0)	Direct

Footnotes

F1: The stock option will vest and become exercisable 1/48th each month over the four year period.